HEP DYNAMICS

Led by Roger Green, we are a commercial planning and product development for early-stage healthcare products companies.

[HEP DYNAMICS @HepDynamics]

Surfing NASH now has it's own Twitter account… Follow the podcast at @surfing_NASH #SurfingNASH #NAFLD #FattyLiver

[SurfingMASH @surfing_MASH]

Welcome to Surfing NASH Tsunami - The Podcast… Driving The Discussion of Fatty Liver Disease… #SurfingNASH #FattyLiver #NAFLD #HepDynamics https://t.co/oTi7I6WHCs

[SurfingMASH @surfing_MASH]

Surf Live this weekend at NASH-TAG 2022 - Join Roger Green and guests live as they cover this year's NASH-TAG Event
Register for Live Link: https://t.co/5U316oF9sQ

#nashtag #NAFLD #fattyliver #liverpodcast #nashpodcast

[SurfingMASH @surfing_MASH]

MORE: https://t.co/QHEViHIMNv

#DiagnosticTests #DrugTrial #education #Elastography #LeanNASH #MRIPDFF #NAFLD #NASH #Obesity #PatientReportedOutcomes #populationscreening #ParisNASHConference #ArunSanyal #LawrenceSerfaty #AntarosMedical #stellatecells

[SurfingMASH @surfing_MASH]

…is so enthusiastic about the FDA's recent approval of the ELF test as a prognostic test for cirrhosis.

MORE: https://t.co/LUgEqMR1lu

#cirrhosis #DiagnosticTests #EchoSens #education #ELF #FibroScan #NAFLD #NASH #noninvasivelivertesting #Siemens #SiemensHealthineers

[SurfingMASH @surfing_MASH]

September 10, 2021
Surfing the NASH Tsunami Hits 25,000 downloads

Remember when Surfing the NASH Tsunami hit 20,000 Buzzsprout downloads on July 9? That was so two months ago!

[SurfingMASH @surfing_MASH]

MORE: https://t.co/T2x3egjHc9

#Diabetes @Echosens #education #ELF #FibroScan @GlobalLiver #NAFLD #NASH @KnowledgeNash #NHANES #noninvasivelivertesting #Obesity #PatientAdvocacy #populationscreening @SiemensHealthineers #socialpolicy @TawazunH #Prevalencestudies @LiverSaver

[SurfingMASH @surfing_MASH]

S2-E45 - Ask the Advocates: The Biggest NAFLD/NASH Story of the Summer

Louise Campbell and Roger Green interview patients/patient advocates Donna Cryer, Wayne Eskridge and Anthony Villiotti about what each considers the biggest NAFLD story of the summer.

[SurfingMASH @surfing_MASH]

September 4, 2021

S2-E44.1 - COVID-19 And Fatty Liver: How Immunocompromised and Transplant Patients Became A Priority for Booster Doses

MORE: https://t.co/1ObxyuCxqc

[SurfingMASH @surfing_MASH]

August 29, 2021

S2-E43.3 – Driving A Reconsideration Of Cirrhosis In Drug Development

@schattenbergJ joins the Surfers to discuss drug development in cirrhosis. This conversation focuses on how to drive a broader change in perspective

[SurfingMASH @surfing_MASH]

S2-E42.3 - 𝗪𝗵𝘆 𝗙𝗚𝗙𝘀 𝗠𝗮𝘁𝘁𝗲𝗿 - 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝗢𝗽𝗲𝗻𝗶𝗻𝗴 𝗮𝗻𝗱 𝗖𝗹𝗼𝘀𝗶𝗻𝗴 - 𝗣𝗹𝘂𝘀 𝗮 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻 𝗔𝗯𝗼𝘂𝘁 𝗦𝗰𝗿𝗲𝗲𝗻 𝗙𝗮𝗶𝗹 𝗥𝗮𝘁𝗲𝘀

MORE INFO: https://t.co/nwei5c9Cr7

#89bio #AkeroTherapeutics #aldafermin #dapagliflozin #efruxifermin

[SurfingMASH @surfing_MASH]

August 20, 2021 - S2-E42 — 𝗪𝗵𝗼 𝗶𝘀 𝗕𝗲𝘁𝘁𝗲𝗿 𝘁𝗼 𝗘𝘅𝗽𝗹𝗮𝗶𝗻 𝗙𝗚𝗙𝘀 𝘁𝗵𝗮𝗻 𝗔𝗿𝘂𝗻 𝗦𝗮𝗻𝘆𝗮𝗹 𝗮𝗻𝗱 𝗦𝘁𝗲𝗽𝗵𝗲𝗻 𝗛𝗮𝗿𝗿𝗶𝘀𝗼𝗻❓

[HEP DYNAMICS @HepDynamics]

The first part of this episode addresses the history and key contents of the recent paper, “Preparing for the NASH Epidemic: A Call to Action,” in press or appearing in several major journals… #NASH #SurfingNASH

[SurfingMASH @surfing_MASH]

Thursday, August 12 2021 — Co-authors Kenneth Cusi and Stephen Harrison discuss the multidisciplinary call to action regarding the coming NASH Epidemic, how the first paper came to be and what lies behind it… https://t.co/uaWiag9cey

[SurfingMASH @surfing_MASH]

𝗛𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗳𝗶𝗻𝗱 𝟮𝟱𝗞 𝗨𝗦 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗱𝗶𝘃𝗲𝗿𝘀𝗲 𝗯𝗮𝗰𝗸𝗴𝗿𝗼𝘂𝗻𝗱𝘀❓​

While Roger Green was away, Donna Cryer hosted a conversation focusing on recruiting patients from underserved communities.

[HEP DYNAMICS @HepDynamics]

Follow @surfing_NASH for conversations on Fatty Liver Disease

[SurfingMASH @surfing_MASH]

S2 E16.1 — How cost-effectiveness research on Widespread NIT screening in the U.S. Has Evolved

https://t.co/TibPzyK2zu

[HEP DYNAMICS @HepDynamics]

@surfing_NASH is driving the discussion of #FattyLiver and #NAFLD

[SurfingMASH @surfing_MASH]

Cost-effectiveness of Widespread Non-Invasive NASH Testing and Treatment

https://t.co/U261GhrOV3

[HEP DYNAMICS @HepDynamics]

Follow @surfing_NASH for all things about #NASH, #NAFLD, and #FattyLiver

[SurfingMASH @surfing_MASH]

Evolution in Clinical Trials: Platform Trials and Digital Histology

https://t.co/YYrXU8oILF

Our coverage of NASH-TAG featured commentary and debate, not regurgitation of facts.

[HEP DYNAMICS @HepDynamics]

Our newsest episode about @NashTagConf 2021

[SurfingMASH @surfing_MASH]

S2-E15 — Wrapping Up NASH-TAG 2021

https://t.co/9sAKkCWEUf

Surfing the NASH Tsunami closes the book on NASH-TAG 2021 by considering highlights and major themes of the conference.

[HEP DYNAMICS @HepDynamics]

The Perfect Wave To Start… Top 8 Episodes… let's get surfing!

[SurfingMASH @surfing_MASH]

Have you heard? These are our top 8 episodes…

https://t.co/oLxcFk4rNG

Over 10,000 downloads… it's a lot to listen to! Here's our most listened to episodes… Now available in over 20 Podcast Apps.

#NASH #NAFLD #FDA #COVID #TLMdX #DIGITALILC #FattyLiver #SurfingNASH

[SurfingMASH @surfing_MASH]

S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses

https://t.co/FDoSJsTfOT

[HEP DYNAMICS @HepDynamics]

On no! While @buzzsprout works on their system issues... try Spotify https://t.co/pmYozVwmfS

[SurfingMASH @surfing_MASH]

1/ Shout out to @Spotify for keeping our episodes available!

Our podcast publisher Buzzsprout is currently a victim of a DDoS attack and is working on getting their system back online.

Find the episodes here: https://t.co/jiMd7Jwx6u

[HEP DYNAMICS @HepDynamics]

Follow @surfing_NASH for information about the most listened podcast about Fatty Liver Disease.

[SurfingMASH @surfing_MASH]

https://t.co/JLoFsQiin6

The Surfers and guests Manal Abdelmalek, Naim Alkhouri and Akero Therapeutics Chief Development Officer Kitty Yale discuss sections of the FDA Webcast that centered on clinical and surrogate endpoints.